Ingredion (INGR) Investor Day 2025 summary
Event summary combining transcript, slides, and related documents.
Investor Day 2025 summary
8 Jul, 2026Strategic vision and transformation
Transitioned from an ingredients company to a solutions provider, focusing on value creation, disciplined capital allocation, risk management, and operational excellence.
Pursuing business transformation through portfolio optimization, innovation, and cost competitiveness to strengthen market leadership and maximize shareholder returns.
Completed business resegmentation, divested non-core assets, and achieved record EBITDA, EPS, and cash, exceeding prior growth targets.
Achieved record 2024 results: adjusted diluted EPS of $10.65 (+13% YoY), $1.4B cash from operations (+36% YoY), and gross profit margin of 24.1% (+270bps YoY).
Emphasizes global reach with local expertise, leveraging deep customer relationships and diversified product mix across 16,000 customers in 22 countries.
Segment performance and growth outlook
Texture and Healthful Solutions segment targets 4%-6% net sales growth and 28%-30% gross profit margins, with 8%-10% adjusted operating income CAGR (2025-2027), driven by clean label and innovation.
LATAM segment leverages a century-long presence, local manufacturing, and a broad portfolio to target 2%-3% net sales growth and 26%-28% gross margins, with 5%-6% adjusted operating income CAGR.
US-Canada segment focuses on stable cash generation, margin expansion (21%-23% gross margin), and portfolio diversification, targeting 0%-1% net sales CAGR and 1%-2% adjusted operating income CAGR.
Industrial applications and sustainable packaging are growth areas, with investments in biodegradable binders and PFAS-free solutions.
The 'Other' segment, including protein fortification and sugar reduction, is improving profitability and expected to contribute more significantly.
Innovation and operational excellence
R&D investments focus on texture science, clean label, sugar reduction, protein technology, and AI-driven predictive formulation.
Over 500 R&D associates in 30 labs drive $300M in annual new product sales, with 3% of Texture and Healthful Solutions sales reinvested in R&D.
Proprietary data and advanced imaging techniques enable faster, more successful product launches and co-creation with customers.
Launched new clean label texturizing fibers and piloted first-to-market texture solutions service.
Operational excellence initiatives, including global procurement and supply chain optimization, have delivered millions in savings and improved service metrics.
Latest events from Ingredion
- Q2 adjusted EPS up 24% and full-year outlook raised, despite lower net sales.INGR
Q2 20249 Jul 2026 - Record Q3 profit and margin gains drive raised outlook and strong cash flow.INGR
Q3 20248 Jul 2026 - Operating and net income rose with margin gains, offsetting sales declines; outlook raised.INGR
Q2 20258 Jul 2026 - Record profit growth and margin expansion in 2024 set the stage for further gains in 2025.INGR
Q4 20248 Jul 2026 - $5B (£3.7B) acquisition forms a global ingredient leader, targeting $130M in synergies by 2030.INGR
M&A announcement8 Jun 2026 - All agenda items passed, with management emphasizing resilience and growth amid global challenges.INGR
AGM 202620 May 2026 - Q1 2026 operating income fell on Argo issues and weak volumes, but Texture & Healthful Solutions grew.INGR
Q1 20268 May 2026 - Record adjusted EPS and segment growth in 2025, with a stable 2026 outlook.INGR
Q4 202520 Apr 2026 - Proxy covers director elections, executive pay, auditor ratification, and major ESG progress.INGR
Proxy filing8 Apr 2026